NCT03794557View on ClinicalTrials.gov

The Effect of Inhaled PUL-042 on Rhinovirus-induced Symptoms in Smokers With GOLD Stage 0 COPD

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 21, 2019

Primary Completion Date

December 16, 2020

Study Completion Date

March 23, 2021

Conditions

COPD

Interventions

DRUG

Sterile Water Injection

Inhaled Sterile Water Injection

DRUG

PUL-042 Inhalation Solution

PUL-042 Inhalation Solution

Trial Locations (1)

W2 1 NY

Imperial College Healthcare NHS Trust, St Mary Hospital, London

Sponsors

Collaborators (1)

MWB Consulting Ltd

All Listed Sponsors

collaborator

Imperial College Healthcare NHS Trust

OTHER

collaborator

VirTus Respiratory Research Ltd

UNKNOWN

collaborator

MWB Consulting Ltd

UNKNOWN

collaborator

Data Magik Ltd

UNKNOWN

lead

Pulmotect, Inc.

INDUSTRY